24
|
Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger, Jr. JI, Craddock N, DePaulo JR, Baron M, Gershon ES, Ekholm J, Cichon S, Turecki G, Claes S, Kelsoe JR, Schofield PR, Badenhop RF, Morissette J, Coon H, Blackwood D, McInnes LA, Foroud T, Edenberg HJ, Reich T, Rice JP, Goate A, McInnis MG, McMahon FJ, Badner JA, Goldin LR, Bennett P, Willour VL, Zandi PP, Liu J, Gilliam C, Juo SH, Berrettini WH, Yoshikawa T, Peltonen L, Lönnqvist J, Nöthen MM, Schumacher J, Windemuth C, Rietschel M, Propping P, Maier W, Alda M, Grof P, Rouleau GA, Del-Favero J, Van Broeckhoven C, Mendlewicz J, Adolfsson R, Spence MA, Luebbert H, Adams LJ, Donald JA, Mitchell PB, Barden N, Shink E, Byerley W, Muir W, Visscher PM, Macgregor S, Gurling H, Kalsi G, McQuillin A, Escamilla MA, Reus VI, Leon P, Freimer NB, Ewald H, Kruse TA, Mors O, Radhakrishna U, Blouin JL, Antonarakis SE, Akarsu N. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 2003; 73:49-62. [PMID: 12802785 PMCID: PMC1180589 DOI: 10.1086/376547] [Citation(s) in RCA: 319] [Impact Index Per Article: 15.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2002] [Accepted: 04/09/2003] [Indexed: 01/20/2023] Open
Abstract
Genome scans of bipolar disorder (BPD) have not produced consistent evidence for linkage. The rank-based genome scan meta-analysis (GSMA) method was applied to 18 BPD genome scan data sets in an effort to identify regions with significant support for linkage in the combined data. The two primary analyses considered available linkage data for "very narrow" (i.e., BP-I and schizoaffective disorder-BP) and "narrow" (i.e., adding BP-II disorder) disease models, with the ranks weighted for sample size. A "broad" model (i.e., adding recurrent major depression) and unweighted analyses were also performed. No region achieved genomewide statistical significance by several simulation-based criteria. The most significant P values (<.01) were observed on chromosomes 9p22.3-21.1 (very narrow), 10q11.21-22.1 (very narrow), and 14q24.1-32.12 (narrow). Nominally significant P values were observed in adjacent bins on chromosomes 9p and 18p-q, across all three disease models on chromosomes 14q and 18p-q, and across two models on chromosome 8q. Relatively few BPD pedigrees have been studied under narrow disease models relative to the schizophrenia GSMA data set, which produced more significant results. There was no overlap of the highest-ranked regions for the two disorders. The present results for the very narrow model are promising but suggest that more and larger data sets are needed. Alternatively, linkage might be detected in certain populations or subsets of pedigrees. The narrow and broad data sets had considerable power, according to simulation studies, but did not produce more highly significant evidence for linkage. We note that meta-analysis can sometimes provide support for linkage but cannot disprove linkage in any candidate region.
Collapse
Affiliation(s)
- Ricardo Segurado
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, Dublin 2, Ireland.
| | - Sevilla D. Detera-Wadleigh
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Douglas F. Levinson
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Cathryn M. Lewis
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Michael Gill
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - John I. Nurnberger, Jr.
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Nick Craddock
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - J. Raymond DePaulo
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Miron Baron
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Elliot S. Gershon
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Jenny Ekholm
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Sven Cichon
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Gustavo Turecki
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Stephan Claes
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - John R. Kelsoe
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Peter R. Schofield
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Renee F. Badenhop
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - J. Morissette
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Hilary Coon
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Douglas Blackwood
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - L. Alison McInnes
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Tatiana Foroud
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Howard J. Edenberg
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Theodore Reich
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - John P. Rice
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Alison Goate
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Melvin G. McInnis
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Francis J. McMahon
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Judith A. Badner
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Lynn R. Goldin
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Phil Bennett
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Virginia L. Willour
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Peter P. Zandi
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Jianjun Liu
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Conrad Gilliam
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Suh-Hang Juo
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Wade H. Berrettini
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Takeo Yoshikawa
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Leena Peltonen
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Jouko Lönnqvist
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Markus M. Nöthen
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Johannes Schumacher
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Christine Windemuth
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Marcella Rietschel
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Peter Propping
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Wolfgang Maier
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Martin Alda
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Paul Grof
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Guy A. Rouleau
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Jurgen Del-Favero
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Christine Van Broeckhoven
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Julien Mendlewicz
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Rolf Adolfsson
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - M. Anne Spence
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Hermann Luebbert
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Linda J. Adams
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Jennifer A. Donald
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Philip B. Mitchell
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Nicholas Barden
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Eric Shink
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - William Byerley
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Walter Muir
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Peter M. Visscher
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Stuart Macgregor
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Hugh Gurling
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Gursharan Kalsi
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Andrew McQuillin
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Michael A. Escamilla
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Victor I. Reus
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Pedro Leon
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Nelson B. Freimer
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Henrik Ewald
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Torben A. Kruse
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Ole Mors
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Uppala Radhakrishna
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Jean-Louis Blouin
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Stylianos E. Antonarakis
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| | - Nurten Akarsu
- Neuropsychiatric Genetics Unit, Department of Genetics, Trinity College, and Trinity Centre for Health Sciences, Department of Psychiatry, St. James Hospital, Dublin; Mood and Anxiety Disorders Program, National Institute of Mental Health/National Institutes of Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia; Division of Genetics and Development, Guy’s, King’s & St Thomas’ School of Medicine, and Molecular Psychiatry Laboratory, Windeyer Institute for Medical Science, Department of Psychiatry and Behavioral Sciences, Royal Free and University College Medical School, University College London, London; Departments of Psychiatry, Medical and Molecular Genetics, and Biochemistry and Molecular Biology, Indiana University, Indianapolis; Molecular Psychiatry Group, Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Edgbaston, Birmingham, United Kingdom; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore; Division of Psychiatric Genetics, Department of Medical Genetics, Columbia University, New York State Psychiatric Institute, and Departments of Psychiatry and Human Genetics, Mount Sinai School of Medicine, New York; Department of Psychiatry, University of Chicago, Chicago; Department of Molecular Medicine, National Public Health Institute, and Department of Medical Genetics, University of Helsinki, and Department of Mental Health, National Public Health Institute, Helsinki; Departments of Medical Genetics and Psychiatry, University of Antwerp, and Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Antwerp, Belgium; Department of Psychiatry and Centre for Research in Neuroscience, The Montreal General Hospital Research Institute, McGill University, Montreal; Laboratory of Psychiatric Genomics, Department of Psychiatry, University of California San Diego (UCSD), La Jolla; Garvan Institute of Medical Research, School of Psychiatry, University of New South Wales, and Mood Disorders Unit, Prince of Wales Hospital, and School of Biological Science, Macquarie University, Sydney; Neuroscience Centre Hospitalier de l'Université Laval Research Center and Laval University, Quebec; University of Utah, Salt Lake City; Psychiatry and Biological Sciences, University of Edinburgh, Edinburgh; Department of Psychiatry, Washington University School of Medicine, St. Louis; Laboratory for Molecular Psychiatry, RIKEN (Institute of Physical and Chemical Research) Brain Science Institute, Saitama, Japan; Departments of Human Genetics and Psychiatry, University of California, Los Angeles; Institute of Human Genetics, Institute for Medical Biometry, Informatics, and Epidemiology, and Department of Psychiatry, University of Bonn, Bonn, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, Dalhousie University, Halifax, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada; Department of Psychiatry, Erasme Hospital, University of Brussels, Brussels; Department of Clinical Sciences Division of Psychiatry University of Umea, Umea, Sweden; Departments of Pediatrics and Psychiatry, University of California, Irvine; Biofrontera Pharmaceuticals, Leverkusen, Germany; Department of Psychiatry, University of Texas Health Science Center, San Antonio; Department of Psychiatry, University of California, San Francisco; Centro de Biología Molecular y Celular and Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica; Institute for Basic Psychiatric Research, Aarhus University Hospital, Risskov, Denmark; Department of Clinical Biochemistry and Genetics, Odense University Hospital, Odense, Denmark; Department of Medical Genetics, University of Geneva Medical School and University Hospitals, Geneva, Switzerland; and Department of Pediatrics, Hacettepe University, Ankara, Turkey
| |
Collapse
|